Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Meal suggestions take the pressure off deciding what to eat when appetite is low
If your genetic profile shows strong GIP pathway activity but weak isolated GLP-1 response, tirzepatide's dual-agonist mechanism aligns better with your biology
Clinicians should consider prioritising review for people with type 2 diabetes on the affected GLP-1 RA preparation where: HbA1c greater than 86mmol/mol in the previous 3 to 6 months HbA1c greater than 86mmol/mol prior to starting the GLP1-RA HbA1c not recorded in the previous 6 months Urine albumin creatinine ratio (uACR) greater than 30mg/mmol Self-monitoring glucose readings (or Continuous Glucose Monitoring, where available) are persistently above individualised target range
Dosing time matters
US$ 23.90
US$ 27.45
US$ 27.77
US$ 24.39
